Skip Navigation


IJE Advance Access originally published online on January 19, 2008
International Journal of Epidemiology 2008 37(1):1-3; doi:10.1093/ije/dym289
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
37/1/1    most recent
dym289v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Davey Smith, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Davey Smith, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.

Editor's Choice

Big business, big science?

George Davey Smith

E-mail: George.Davey-Smith@bris.ac.uk

The first 10% of the full text of this article appears below.

What is the appropriate nature of the relationship between researchers and their sponsors or employers? This question receives an energetic outing in the current issue of the IJE. Neil Pearce—president elect of the International Epidemiological Association (IEA), the organization for which the IJE is produced—makes a compelling case that corporate influences can distort the knowledge base of epidemiology.1 He relates the story of how research on the adverse effects of an asthma drug, fenoterol, was attacked by epidemiologists working as the hired guns of industry, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?